title: Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas.
authors.forename: G
authors.initials: G
authors.lastname: Di Stefano
authors.forename: C
authors.initials: C
authors.lastname: Busi
authors.forename: L
authors.initials: L
authors.lastname: Fiume
authors.forename: P
authors.initials: P
authors.lastname: Chieco
authors.forename: M
authors.initials: M
authors.lastname: Pariali
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004317:Doxorubicin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004337:Drug Carriers; D007413:Intestinal Mucosa / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy*; D009206:Myocardium / Q000378:metabolism; D051381:Rats; D012709:Serum Albumin / Q000008:administration & dosage*; D014018:Tissue Distribution
chemical_list: D000903:Antibiotics, Antineoplastic; D004337:Drug Carriers; D012709:Serum Albumin; C046912:lactosaminated serum albumin; D004317:Doxorubicin